1. Home
  2. XCUR

as 07-08-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

Founded: 2011 Country:
United States
United States
Employees: N/A City: CHICAGO
Market Cap: 3.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 68.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.52 EPS Growth: N/A
52 Week Low/High: $0.30 - $1.47 Next Earning Date: 08-09-2024
Revenue: $500,000 Revenue Growth: -98.10%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

XCUR Daily Stock ML Predictions

Stock Insider Trading Activity of Exicure Inc. (XCUR)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
DGP Co., Ltd. XCUR 10% Owner Feb 29 '24 Sell $1.32 3,400,000 $4,488,000.00 0 SEC Form 4

Share on Social Networks: